Morgan Stanley’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Sell
64,848
-29,587
-31% -$728K ﹤0.01% 4767
2025
Q4
$1.97M Sell
94,435
-10,298
-10% -$191K ﹤0.01% 4821
2025
Q3
$1.64M Sell
104,733
-55,697
-35% -$1.15M ﹤0.01% 4903
2025
Q2
$3.19M Sell
160,430
-3,805
-2% -$77.1K ﹤0.01% 4404
2025
Q1
$2.91M Buy
164,235
+146,820
+843% +$4.79M ﹤0.01% 4346
2024
Q4
$804K Buy
17,415
+4,094
+31% +$173K ﹤0.01% 5201
2024
Q3
$404K Buy
13,321
+132
+1% +$2.41K ﹤0.01% 5502
2024
Q2
$217K Sell
13,189
-120
-0.9% -$1.92K ﹤0.01% 5631
2024
Q1
$204K Sell
13,309
-91,401
-87% -$1.45M ﹤0.01% 5726
2023
Q4
$1.71M Buy
104,710
+61,277
+141% +$1.05M ﹤0.01% 5008
2023
Q3
$803K Sell
43,433
-44,006
-50% -$778K ﹤0.01% 4926
2023
Q2
$997K Buy
87,439
+70,535
+417% +$797K ﹤0.01% 4832
2023
Q1
$203K Sell
16,904
-28,382
-63% -$395K ﹤0.01% 5706
2022
Q4
$387K Buy
45,286
+2,643
+6% +$23.3K ﹤0.01% 5371
2022
Q3
$329K Sell
42,643
-1,947
-4% -$21.6K ﹤0.01% 5479
2022
Q2
$492K Buy
44,590
+5,618
+14% +$66.2K ﹤0.01% 5435
2022
Q1
$617K Buy
38,972
+14,088
+57% +$291K ﹤0.01% 5285
2021
Q4
$1.15M Sell
24,884
-5,126
-17% -$294K ﹤0.01% 4968
2021
Q3
$2.01M Sell
30,010
-7,377
-20% -$605K ﹤0.01% 4576
2021
Q2
$3.99M Sell
37,387
-1,045
-3% -$124K ﹤0.01% 4019
2021
Q1
$5.85M Buy
38,432
+15,633
+69% +$2.54M ﹤0.01% 3246
2020
Q4
$3.81M Buy
22,799
+17,947
+370% +$3.19M ﹤0.01% 3557
2020
Q3
$758K Sell
4,852
-1,002
-17% -$202K ﹤0.01% 4402
2020
Q2
$1.23M Sell
5,854
-212
-3% -$43.7K ﹤0.01% 4010
2020
Q1
$1.13M Buy
6,066
+805
+15% +$190K ﹤0.01% 3859
2019
Q4
$1.27M Sell
5,261
-2,486
-32% -$479K ﹤0.01% 4370
2019
Q3
$1.31M Buy
7,747
+3,099
+67% +$702K ﹤0.01% 4123
2019
Q2
$907K Buy
4,648
+1,503
+48% +$324K ﹤0.01% 4272
2019
Q1
$832K Buy
3,145
+2,364
+303% +$432K ﹤0.01% 4239
2018
Q4
$156K Sell
781
-312
-29% -$95K ﹤0.01% 5382
2018
Q3
$681K Buy
1,093
+974
+818% +$432K ﹤0.01% 4808
2018
Q2
$41K Buy
+119
New +$42.9K ﹤0.01% 5962

Other funds holding TECX